Clinical Report: Ultrasound Assessment of Histological Progression in Primary Biliary Cholangitis
Overview
This study evaluates the use of two-dimensional ultrasound measurement of the periportal hypoechoic band (PHB) width as a non-invasive method to assess histological staging in primary biliary cholangitis (PBC). The findings suggest that PHB width correlates with disease progression and offers a reproducible, accessible alternative to liver biopsy and transient elastography.
Background
Primary biliary cholangitis (PBC) is a progressive autoimmune liver disease characterized by inflammation and destruction of small bile ducts, often leading to liver failure within a decade without treatment. Accurate staging of PBC is critical for guiding therapy, with early stages benefiting from anti-inflammatory treatment and later stages focusing on symptom management. Liver biopsy remains the gold standard for staging but is limited by invasiveness and sampling variability. Transient elastography is recommended but not universally available and has technical limitations. Imaging changes around portal vein branches, such as the periportal hypoechoic band (PHB) on ultrasound, may reflect histological changes in PBC.
Data Highlights
Parameter
PBC Patients (n=77)
HBV Controls (n=56)
Ultrasound PHB Width
Measured around left portal vein branch, averaged over 3 measurements
Not specified
Histological Staging
Ludwig system stages 1-4
METAVIR fibrosis scores F0-F4
Inter-observer Agreement
Assessed in 10 PBC patients with double-blind exams
Not applicable
Observer Consistency
Measured in 8 PBC patients by 3 sonographers with varying experience
Not applicable
Key Findings
The width of the periportal hypoechoic band (PHB) on ultrasound correlates with histological stage of PBC, increasing with disease progression.
PHB measurement is reproducible with good inter-observer agreement among sonographers with different levels of experience.
Ultrasound detection of PHB provides a simple, quick, and non-invasive method to assess PBC progression compared to invasive liver biopsy.
PHB changes reflect periportal inflammation, fibrosis, and cholestasis consistent with histological findings in PBC.
Compared to hepatitis B virus (HBV) controls, PBC patients show distinct periportal ultrasound features related to disease pathology.
Clinical Implications
Measurement of the periportal hypoechoic band via routine abdominal ultrasound offers a practical, widely accessible tool for clinicians to non-invasively monitor histological progression in PBC patients. This technique may reduce reliance on liver biopsy and transient elastography, especially in settings where these are unavailable or contraindicated. Early identification of disease progression through PHB measurement can guide timely therapeutic interventions.
Conclusion
Two-dimensional ultrasound measurement of the periportal hypoechoic band is a promising, non-invasive approach to assess histological staging in primary biliary cholangitis. This method enhances clinical evaluation and may improve management by facilitating earlier detection of disease progression.
References
Ludwig et al. 1987 -- Histological staging of primary biliary cirrhosis
EASL Clinical Practice Guidelines 2017 -- Primary biliary cholangitis
METAVIR scoring system -- Liver fibrosis assessment
MRI halo ring sign studies -- Periportal fibrosis and inflammation in PBC
